GSK3B and craniodiaphyseal dysplasia: To validate the effect of C11 in CDD we selected, as an in vitro model, a recently generated human cellular model of CDKL5 deficiency that exhibited alterations in the GSK-3β signal pathway [19] as well as reduced survival and differentiation.